Ms. Hanley is practice group leader of the firm's Intellectual Property/Information Technology Group and has more than thirty years of experience as a patent professional. She began her career as an Examiner at the U.S. Patent and Trademark Office in the fields of biotechnology and chemistry. While employed by the Patent Office, she received specialized biotechnology training at the National Institutes of Health.
Ms. Hanley practices in all areas of chemistry and biotechnology patent law, including patent prosecution, patentability, freedom to operate and validity opinions, licensing, and due diligence evaluations. Her specialties include small molecule and organic chemistry, drug delivery, and pharmaceutical development. She has extensive experience in representing early stage companies and working with them interactively to strategically build their patent portfolios. She also represents many of the leading pharmaceutical companies building and managing complex patent portfolios, protecting blockbuster biotech and small molecule drugs, and developing global strategic plans.
Ms. Hanley has been recognized in Chambers USA from 2009-2016 and Managing IP’s Top 250 Women in IP in 2014. She has also been recognized by The Best Lawyers in America in 2015 and 2016 and recognized in Massachusetts Super Lawyers from 2005-2016. Chambers is published by Chambers and Partners. Super Lawyers is published by Thomson Reuters. Best Lawyersis published by Best Lawyers in partnership with US News and World Report. A description of their selection process can be found in the respective links above. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.